ACHV

Conviction 100HealthcareScan · Thu, Jun 25, 2026

ACHV$5.70+7.45%

ResistanceSupportVol 14

Vol MA14 2.85M

Mar 26Apr 14May 1May 19Jun 8Jun 25

ACHIEVE LIFE SCIENCES, INC.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.achievelifesciences.com ↗

Price5.70

Change+7.45%

Gap-0.38%

Rel volume6.37×

Avg volume2.41M

Avg $ vol12.93M

SMA 205.33

SMA 504.94

SMA 2004.38

Price vs 50+15.37%

Price vs 200+30.11%

MA stackbullish

50/200 cross—

Supertrenddown · 5.76

RSI (14)59

MACD hist-0.03

MACD crossbear · 5d

Stoch %K / %D65 / 41

ADX (14)21

+DI / −DI30 / 17

RSI divergence—

MACD divergence—

ATR %+7.89%

ADR %8.31%

52w high5.99

52w low2.07

From 52w high-4.92%

Above 52w low+175.12%

New 52w highNo

SqueezeOn · 2d

Bollinger width19.11%

%B0.86

Donchian pos68.26%

Donchian high6.16

Donchian low4.70

AVWAP (52w high)5.42

vs AVWAP high+5.06%

AVWAP (52w low)4.09

vs AVWAP low+39.08%

OBV trendUp

Chaikin MF (20)-0.13

Today vs 20d6.37×

Avg vol (14d)2.85M

Avg vol (20d)2.41M

Avg $ vol (20d)12.93M

Market cap584.64M

RS 3m (vs SPY)+70.50%

RS 6m (vs SPY)+14.95%

RS line new highNo

Trend template8/8

Technical rank89.2

1 week+6.25%

1 month+24.89%

3 months+101.95%

6 months+27.69%

1 year+49.48%

YTD+14.59%

P/E-10.70

P/B54.75

P/S—

P/FCF-11.82

EPS-1.25

Div yield—

ROE-511.78%

ROA-165.07%

Debt/Eq—

Current2.62

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-37.21%

Price target13.20

Target upside131.78%

Analyst ratingBuy

Institutional23.63%

Ent. value556.57M

Revenue—

Net income-10.17M

Gross profit—

Free cash flow-49.47M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out102.66M

Employees28

ListedThu, Oct 12, 1995

Free float39.1M

Float %73.5%

Short interest7.68M

Days to cover5.5d

Short volume33.7%

Squeeze score79 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.20 · 2 est

Last EPS vs est−$0.19 vs −$0.30

Last surprise+36.7% beat

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank89.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.16

Support4.46

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACHV

All disclosures →

No recent disclosed trades by Congress in ACHV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACHV · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Waldman Reid Alexander Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Farrow Jeffrey S Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Martin Christopher Nathan Director · Stock Option (right to buy) · 2026-05-11	Grant	47.25K	$0	2026-05-11	2026-05-13
Goldberg Andrew D. CEO and President · Performance Restricted Stock Unit (PRSU) · 2026-04-18	Grant	11.71M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Restricted Stock Unit (RSU) · 2026-04-18	Grant	1.8M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Stock Option (right to buy) · 2026-04-18	Grant	3.6M	$0	2026-04-18	2026-04-21

SEC filings

EDGAR filings in ACHV · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.